What is the management of preterm prelabor rupture of membranes (PPROM) in a pregnant woman, according to the American College of Obstetricians and Gynecologists (ACOG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Preterm Prelabor Rupture of Membranes (PPROM) According to ACOG

ACOG-endorsed guidelines recommend a gestational age-based approach to PPROM management, with individualized counseling about abortion care versus expectant management for previable/periviable cases (<24 weeks), and expectant management with antibiotics, corticosteroids, and close surveillance for cases ≥24 weeks until delivery is indicated. 1

Initial Assessment and Diagnosis

When PPROM is suspected, confirm the diagnosis and immediately assess for:

  • Maternal fever ≥38°C (100.4°F), maternal or fetal tachycardia, purulent cervical discharge, or uterine tenderness to rule out intraamniotic infection 2
  • Critical caveat: Infection may present without maternal fever, especially at earlier gestational ages—do not delay diagnosis based on absence of fever alone 2
  • Gestational age determination (critical for management decisions) 1
  • Amniotic fluid volume assessment (higher residual volume associated with improved perinatal survival) 2
  • Signs of placental abruption, active labor, or fetal compromise 2

Gestational Age-Specific Management Algorithm

Previable PPROM (<20 weeks)

  • No neonatal survival has been reported after PPROM <16 weeks gestation 2
  • Offer abortion care as a primary option 1
  • If expectant management chosen, counsel about extremely high maternal morbidity risk with minimal chance of neonatal survival 1

Periviable PPROM (20 0/7 to 23 6/7 weeks)

Counseling and Decision-Making:

  • Provide individualized counseling about both abortion care and expectant management options (GRADE 1C recommendation) 1
  • All patients must be offered abortion care; expectant management can also be offered in absence of contraindications 1
  • Present realistic outcome data: Among those choosing expectant management, 37% experience maternal morbidity without neonatal survival, 23% have maternal morbidity with neonatal survival, 24% have no maternal morbidity and no neonatal survival, and only 16% avoid maternal morbidity with neonatal survival 1
  • Neonatal survival rates: 20% after PPROM at 16-19 weeks, 30% at 20-21 weeks, 41% at 22-23 weeks 2

If Expectant Management Chosen:

  • Consider antibiotics (GRADE 2C recommendation)—evidence is weaker than at later gestational ages 1, 2
  • Do NOT administer corticosteroids or magnesium sulfate until gestational age when neonatal resuscitation would be pursued (GRADE 1B) 1, 2
  • Initial hospitalization to ensure stability without preterm labor, abruption, or infection 2

PPROM at 24 0/7 to 33 6/7 weeks

Antibiotic Therapy (GRADE 1B recommendation):

  • Administer IV ampicillin 2g every 6 hours PLUS erythromycin 250mg every 6 hours for 48 hours 2, 3
  • Followed by oral amoxicillin 250mg every 8 hours PLUS erythromycin 333mg every 8 hours for 5 additional days (total 7-day course) 2, 3
  • Azithromycin can substitute for erythromycin when unavailable 2
  • AVOID amoxicillin-clavulanic acid—increases necrotizing enterocolitis risk 2, 3
  • Do not use prolonged or repeated antibiotic courses beyond the standard 7-day regimen 2

Corticosteroids and Magnesium Sulfate:

  • Administer antenatal corticosteroids when neonatal resuscitation would be pursued 1
  • Administer magnesium sulfate for neuroprotection when delivery is imminent and neonatal resuscitation would be pursued 1

Surveillance Protocol:

  • Initial hospitalization for stabilization 2
  • After stabilization, outpatient management with close monitoring is reasonable 2
  • Weekly outpatient visits for maternal vital signs, fetal heart rate, physical examination, and laboratory evaluation for leukocytosis 2
  • Daily patient self-monitoring for temperature, vaginal bleeding, discolored or malodorous discharge, contractions, and abdominal pain 2

Hospital Readmission Criteria:

  • Signs of infection (fever, tachycardia, purulent discharge, uterine tenderness) 2
  • Vaginal hemorrhage or suspected abruption 2
  • Fetal demise or compromise on surveillance testing 2
  • Active labor 2
  • Reaching gestational age when neonatal resuscitation would be appropriate 2

PPROM at 34 0/7 to 36 6/7 weeks

  • Consider delivery versus continued expectant management based on individual circumstances 4, 5
  • After 34 weeks, benefits of delivery increasingly outweigh risks of expectant management 6

Critical Maternal Risks to Monitor

Infection Complications:

  • Intraamniotic infection occurs in 58.1% with expectant management versus 8% with abortion care in previable/periviable PPROM 1
  • Maternal sepsis occurs in up to 6.8% of previable/periviable PPROM cases 1, 2
  • Maternal death rate: 45 per 100,000 patients with previable PPROM 2
  • Infection can progress rapidly—median time from first signs to death is only 18 hours in severe cases 7, 2

Other Maternal Complications:

  • Antepartum hemorrhage/abruption more common with expectant management (41.9% vs 19% with abortion care) 1
  • Overall maternal morbidity: 60.2% with expectant management versus 33.0% with abortion care at <24 weeks (adjusted OR 3.47) 2

Interventions NOT Recommended

  • Serial amnioinfusions: NOT recommended for routine care (GRADE 1B)—two large trials showed no reduction in perinatal morbidity 2
  • Amniopatch: Investigational only, use only in clinical trial settings (GRADE 1B) 1, 2

Cerclage Management

  • Either remove cerclage or leave in situ after discussing risks and benefits (GRADE 2C)—randomized trial showed no pregnancy prolongation benefit with retention 1, 2

Neonatal Complications to Counsel About

  • Pulmonary hypoplasia (especially with early PPROM and oligohydramnios) 2
  • Respiratory distress syndrome and bronchopulmonary dysplasia (up to 50% of survivors) 2
  • Skeletal deformities from compression 2
  • Intraventricular hemorrhage, necrotizing enterocolitis, sepsis, retinopathy of prematurity 2
  • Long-term respiratory problems requiring medications in 50-57% of children 2

Subsequent Pregnancy Management

  • Nearly 50% of immediate subsequent pregnancies result in recurrent preterm birth after previable/periviable PPROM 2
  • Follow guidelines for management of pregnant persons with previous spontaneous preterm birth (GRADE 1C)—typically includes progesterone supplementation and increased surveillance 2

Critical Pitfalls to Avoid

  • Do not delay antibiotic administration in PPROM ≥24 weeks—start immediately upon diagnosis 3
  • Do not wait for maternal fever to diagnose intraamniotic infection—infection can progress without fever, especially at earlier gestational ages 2
  • Do not administer corticosteroids or magnesium sulfate before the gestational age when neonatal resuscitation would be pursued 1
  • Do not use amoxicillin-clavulanic acid—associated with increased necrotizing enterocolitis 2, 3
  • Patients have the right to change management plans throughout care—ensure ongoing access to all options including abortion care 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Preterm Premature Rupture of Membranes (PPROM)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prevention of Neonatal Sepsis in PPROM

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Preterm premature rupture of membranes: diagnosis, evaluation and management strategies.

BJOG : an international journal of obstetrics and gynaecology, 2005

Guideline

Prevention of Postpartum Pelvic Infection in PROM at 37 Weeks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the next step in management for a patient with premature rupture of membranes (PROM) where the cervix remains closed after initial treatment?
What management plan is recommended for a primigravid woman at 20 weeks gestation with a history of preterm premature rupture of membranes (PPROM) at 34 weeks in a previous pregnancy?
What is the most appropriate intervention to prevent Preterm Premature Rupture of Membranes (PPROM) in a pregnant woman with a history of previous PPROM?
In the management of Premature Rupture of Membranes (PROM) without labor at any gestational age, which of the following is excluded: assessment of maternal and fetal wellbeing, confirmation of diagnosis, determination of fetal presentation, or digital cervical examinations?
What is the immediate management for a patient with premature rupture of membranes (PROM)?
What is the recommended vitamin D replacement therapy for elderly patients with vitamin D deficiency and low bone mineral density to improve bone health?
What is the most probable cause of oligoanuria in a patient, potentially with a history of diabetes, considering options such as unilateral obstructing nephrolithiasis, acute prostatitis, neurogenic bladder, or dehydration?
What is the best treatment approach for a pregnant individual with hemorrhoids?
What is the most appropriate next step in management for a newborn with microcephaly, hepatosplenomegaly, pancytopenia, and elevated Aspartate Aminotransferase (AST)/Alanine Aminotransferase (ALT) levels, born to a mother with a history of diabetes?
What is the best approach to diagnose and treat aphthous ulcers in patients, considering their medical history, symptoms, and potential underlying conditions?
What is the significance of the renal nephrometry score in evaluating kidney tumors, particularly in older adults suspected of having renal cell carcinoma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.